Description

NSE notifies listing and trading of 4,70,25,359 bonus equity shares of eClerx Services Limited effective March 17, 2026, with record date of March 13, 2026.

Summary

NSE has notified the listing and trading of equity shares issued pursuant to a bonus issue by eClerx Services Limited. A total of 4,70,25,359 new equity shares will be admitted to dealings on NSE’s Capital Market segment effective March 17, 2026. The shares carry ISIN INE738I01010 and will trade under the symbol ECLERX.

Key Points

  • 4,70,25,359 bonus equity shares of eClerx Services Limited admitted to NSE Capital Market segment
  • Symbol: ECLERX | ISIN: INE738I01010
  • Distinctive number range: 58140906 to 105166264
  • Circular issued under Regulation 3.1.1 of NSE (Capital Market) Trading Regulations Part A
  • Securities identified on the trading system by their designated codes only

Regulatory Changes

No new regulatory changes. This circular is issued in pursuance of existing Regulation 3.1.1 of the National Stock Exchange (Capital Market) Trading Regulations Part A.

Compliance Requirements

  • All NSE members are notified of the new securities admitted to dealings
  • Members must use the designated security codes (symbol: ECLERX) to identify and trade these securities on the system

Important Dates

  • Circular Date: March 10, 2026
  • Record Date: March 13, 2026
  • Deemed Date of Allotment: March 16, 2026
  • Effective Date for Listing & Trading: March 17, 2026

Impact Assessment

The bonus issue will increase the total share count of eClerx Services Limited by 4,70,25,359 shares. Existing shareholders will receive bonus shares proportionally, increasing liquidity in the stock. Trading members should update their systems to account for the revised share count effective March 17, 2026. The stock price is expected to adjust downward proportionally on the ex-bonus date to reflect the increased share count.

Impact Justification

Routine bonus issue listing notification affecting existing shareholders of eClerx Services Limited; no regulatory policy change involved.